Castleman Disease with MDM2/CDK4 Protein Expression: a Potential Mimic of Inflammatory Variant of Liposarcoma with Significant Consequences

被引:1
|
作者
Georgantzoglou, Natalia [1 ]
Baker, Michael [1 ,2 ]
Liu, Xiaoying [1 ,2 ]
Kerr, Darcy A. [1 ,2 ]
Linos, Konstantinos [1 ,2 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA
[2] Geisel Sch Med Dartmouth, Hanover, NH USA
关键词
Castleman disease; well-differentiated liposarcoma; dedifferentiated liposarcoma; inflammatory liposarcoma; retroperitoneum; DENDRITIC CELL-SARCOMA; WELL-DIFFERENTIATED LIPOSARCOMA; MDM2; ABNORMALITIES; TUMOR;
D O I
10.1177/10668969221080083
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Castleman disease is a rare benign lymphoproliferative disorder that includes a spectrum of distinct histopathological entities. The differential diagnosis of Castleman disease is broad and includes lymphomas, HIV-related lymphadenopathy, autoimmune disorders, and inflammatory liposarcoma. When Castleman disease occurs in the retroperitoneum, the distinction from the inflammatory variant of well-differentiated liposarcoma can be very challenging in small biopsies. Herein we report a case of Castleman disease that presented as a retroperitoneal mass and expressed MDM2 and CDK4 by immunohistochemistry. To our knowledge, this is the first report of Castleman disease staining positively for MDM2/CDK4, and it underscores how immunohistochemistry can potentially serve as a pitfall when differentiating this rare entity from retroperitoneal sarcomas.
引用
收藏
页码:753 / 759
页数:7
相关论文
共 50 条
  • [31] Investigating the effect of CDK4/6 and MDM2 inhibition on melanoma
    Slesur, Lauren
    Vilgelm, Anna
    Al-Rohil, Rami
    Richmond, Ann
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [32] Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?
    Hanan Alshenawy
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1073 - 1081
  • [33] MDM2 AND CDK4 GENE AMPLIFICATION IN EWINGS-SARCOMA
    LADANYI, M
    LEWIS, R
    JHANWAR, SC
    GERALD, W
    HUVOS, AG
    HEALEY, JH
    JOURNAL OF PATHOLOGY, 1995, 175 (02): : 211 - 217
  • [34] Coordinated expression of MDM2, CDK4 and HMGI-C in atypical lipomatous tumors
    Dei Tos, AP
    Doglioni, C
    Piccinin, S
    Furlanetto, A
    Sciot, R
    Dal Cin, P
    Boiocchi, M
    Fletcher, CDM
    Tallini, G
    MODERN PATHOLOGY, 1998, 11 (01) : 8A - 8A
  • [36] Diagnostic Accuracy of Immunohistochemical Expression of p16, MDM2, and CDK4 in Well-Differentiated and De-Differentiated Liposarcoma in MDM2 Fluorescent in situ Hybridisation Confirmed Cases
    Aslam, Aysha
    Din, Hafeez Ud
    Qadir, Abdul
    Aslam, Umair
    Humayoun, Saba
    Ahmed, Wajahat
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (09): : 1051 - 1055
  • [37] MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas
    Gruenewald, Inga
    Trautmann, Marcel
    Busch, Alina
    Bauer, Larissa
    Huss, Sebastian
    Schweinshaupt, Petra
    Vollbrecht, Claudia
    Odenthal, Margarete
    Quaas, Alexander
    Buettner, Reinhard
    Meyer, Moritz F.
    Beutner, Dirk
    Huettenbrink, Karl-Bernd
    Wardelmann, Eva
    Stenner, Markus
    Hartmann, Wolfgang
    ONCOTARGET, 2016, 7 (46) : 75261 - 75272
  • [38] MDM2 antagonism overcomes resistance to CDK4/6 inhibition in melanoma
    Vilgelm, Anna E.
    Saleh, Nabil
    Riemenschneider, Kelsie
    Slesur, Lauren
    Chen, Sheau-Chian
    Ayers, Gregory D.
    Kauffman, Rondi M.
    Kelley, Mark C.
    Johnson, Douglas B.
    Richmond, Ann
    CANCER RESEARCH, 2018, 78 (13)
  • [39] Coordinated expression of MDM2, CDK4 and HMGI-C in atypical lipomatous tumors.
    Dei Tos, AP
    Doglioni, C
    Piccinin, S
    Furlanetto, A
    Sciot, R
    Dal Cin, P
    Boiocchi, M
    Fletcher, CDM
    Tallini, G
    LABORATORY INVESTIGATION, 1998, 78 (01) : 8A - 8A
  • [40] MDM2 and CDK4 expression in carcinosarcoma of the esophagus: Comparison with squamous cell carcinoma and review of the literature
    Nikitakis, NG
    Drachenberg, CB
    Papadimitriou, JC
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2002, 73 (03) : 198 - 208